The most abundant components of living cells are proteins and peptides. Protein and Peptide are both novel medication delivery systems and novel drug delivery approaches. Peptides can be created to target a wide spectrum of molecules, allowing them to be used in fields as diverse as oncology, immunology, infectious illness, and endocrinology. While the market for peptide and protein therapeutics has grown dramatically in recent decades, their availability has been limited. Peptides and proteins have a lot of therapeutic potential. The market for peptide and protein therapeutics is currently estimated to be worth more than $40 billion per year, accounting for 10% of the total pharmaceutical market. This market is increasing at a far quicker rate than that of small molecules, and it will soon account for a much higher share of the market.
- Peptide Formulation Development
- Oral Delivery
- Transdermal Delivery
- Systemic Peptide Stability & Site-Specific Delivery
- Pharmaceutical Approaches
A C Matin
Stanford University, United States
Tudor Arvinte
Biopharmaceutics University of Geneva, Switzerland
Richard Denk
SKAN AG, Switzerland
Consolato M Sergi
University of Ottawa, Canada
Ruchika Bajaj
University of California, United States
Bhupendra Gopalbhai Prajapati
Shree S.K.Patel College of Pharmaceutical Education and Research, India
Dasharath Muljibhai Patel
Graduate School of Pharmacy, IndiaSubmit your abstract Today
Title : Microemulsion based in situ gel of erythromycin for ocular ailments
Dasharath Muljibhai Patel, Graduate School of Pharmacy, India
Title : Nanomaterial-mediated systemically administered m-RNA-based gene therapy directed exclusively to cancer, present successes and future prospects
A C Matin, Stanford University, United States
Title : Thymoquinone-induced cellular and mitochondrial health in hepatocellular and cholangiocellular carcinoma
Consolato M Sergi, University of Ottawa, Canada
Title : Points to consider for the manufacturing of cell and gene therapies
Richard Denk, SKAN AG, Switzerland
Title : Pharmacological features of sparsentan, a novel dual endothelin and angiotensin receptor antagonist
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Development and validation of RP-HPLC method for the dissolution study of tofacitinib in pharmaceutical solid dosage form
Narapereddy Krishna Prasad, Reckitt Benckiser LLC, United States
Title : Does erector spinae plane block improve respiratory outcomes in adults with rib fractures?
Katie Aldred, University of Liverpool, United Kingdom
Title : Interdisciplinary perspective towards therapeutic potential in antenatal care
Anita, DMIHER, India
Title : Augmented anti-atopic dermatitis effect of crisaborole nanoemulgel in 2,4-Di-nitrochlorobenzene induced (DNCB) atopic dermatitis (AD) in Balb/c mice
Dipti Srivastava, Hygia institute of pharmaceutical education and research, India
Title : Formulation, characterization and evaluation: Micellar loaded complex of cuminum cyminum to treat causing disease of COVID 19 (Respiratory Infection)
Rudra Pratap Singh Rajput, Royal College of Pharmacy, India